Cyclosporine: toxicity, metabolism, and drug interactions--implications from animal studies
Whiting, P.H.; Thomson, A.W.; Simpson, J.G.
Transplantation Proceedings 17(4 Suppl 1: 134-144
1985
ISSN/ISBN: 0041-1345 PMID: 3895654 Document Number: 242950
Document emailed within 1 workday
Related Documents
Cockburn, I. 1986: Cyclosporine A: a clinical evaluation of drug interactions Transplantation Proceedings 18(6 Suppl 5: 50-55Calabrese, E.J. 1980: Does use of oral contraceptives enhance the toxicity of carbon disulfide through interactions with pyridoxine and tryptophan metabolism? Medical Hypotheses 6(1): 21-33
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Krivoy, N.; Zuckerman, T.; Elkin, H.; Froymovich, L.; Rowe, J.M.; Efrati, E. 2012: Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicity Current Drug Safety 7(3): 211-217
Pichard, L.; Fabre, J.M.; Domergue, J.; Fabre, G.; Saint-Aubert, B.; Mourad, G.; Maurel, P. 1991: Molecular mechanism of cyclosporine a drug interactions: inducers and inhibitors of cytochrome P450 screening in primary cultures of human hepatocytes Transplantation Proceedings 23(1 Part 2): 978-979
Mills, C.F. 1981: Interactions between elements in tissues: studies in animal models Federation Proceedings 40(8): 2138-2143
Harada, Y. 1987: Problems presented by animal toxicity studies Progress in Clinical and Biological Research 235: 127-142
Delzenne, N.M.; Verbeeck, R.K. 2001: Interactions of food and drug metabolism Journal de Pharmacie de Belgique 56(2): 33-37
Riess, W.; Walther, G. 1983: Animal experiment studies of the toxicity of tri-xylyl phosphate Beitrage Zur Gerichtlichen Medizin 41: 123-132
Kitagawa, H. 1973: Drug metabolism and toxicity Rinsho Byori. Japanese Journal of Clinical Pathology 21(5): 413-421
Filipczyk-Cisarz, E. 2000: Clinical implications of undesirable consequences of antineoplastic drug interactions Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 9(51): 632-633
Anderson, J.E.; Morris, R.E.; Blaschke, T.F. 1987: Pharmacodynamics of cyclosporine-ketoconazole interaction in mice. Combined therapy potentiates cyclosporine immunosuppression and toxicity Transplantation 43(4): 529-533
Salomon, D.; Brunson, M.; Vansickler, J.; Pfaff, W.; Howard, R.; Peterson, J.; Curry, T.; Thompson, R.; Squiers, E. 1991: A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity Transplantation Proceedings 23(1 Pt 2): 1018-1019
Kauffman, F.C. 1987: Conjugation-deconjugation reactions in drug metabolism and toxicity Federation Proceedings 46(7): 2434-2445
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Tarrús, E.; García, I.; Roberts, D.J.; Segura, J. 1987: An animal model for the detection of drug-induced inhibition of caffeine metabolism Methods and Findings in Experimental and Clinical Pharmacology 9(5): 311-316
Palut, D.; Grzymala, W.; Rózycki, Z. 1970: Studies of the carbaryl C14 metabolism on animal model systems Roczniki Panstwowego Zakladu Higieny 21(4): 417-426
Zhou, J.Q.; Tang, Z.Q.; Zhang, J.N. 2006: An evaluation of para toluene-sulfonamide metabolism and effect with regard to CYP isoforms, P-glycoprotein, and drug interactions Die Pharmazie 61(10): 869-873
Cao, Y.X.; Che, X.P. 1987: Studies on the drug-receptor interactions of dimethyltrilobine iodide Yao Xue Xue Bao 22(6): 462-464
Descotes, J.; Simonet, R.; Loupi, E.; Evreux, J.C. 1986: Drug interactions due to enzymatic inhibition. the predictive value of pharmacokinetic studies Therapie 41(5): 349-351